Acute Oral Toxicity Testing for New Chemical Substances: Guidelines, Methods, and Regulatory Complia

Acute oral toxicity testing is a fundamental hazard evaluation required for the environmental registration of new chemical substances in China and other major jurisdictions worldwide. By determining the median lethal dose (LD50) after a single oral exposure, this test provides the core dataset needed for GHS classification, hazard labeling, safety data sheet preparation, and downstream risk assessment. This article explains the technical principles, applicable standards, sample requirements, testing methods, and regulatory applications of acute oral toxicity testing for new chemical substances.

Technical Overview

Acute oral toxicity refers to the adverse effects that occur in test animals following a single oral administration of a test substance, or multiple oral administrations within a 24-hour period. The principal quantitative endpoint of the study is the median lethal dose (LD50), which is the statistically derived single dose of a substance expected to cause death in 50% of the exposed animals, expressed in milligrams of test substance per kilogram of body weight (mg/kg bw).

For new chemical substances — that is, substances not yet listed on national inventories such as the Inventory of Existing Chemical Substances Produced or Imported in China (IECSC) or the European EINECS/ELINCS inventories — acute oral toxicity data is typically the minimum toxicity information demanded by regulatory authorities. Under China's Measures for the Environmental Management Registration of New Chemical Substances (Ministry of Ecology and Environment Order No. 12, effective January 2021), as well as under the EU REACH Regulation, this endpoint is used to determine whether a substance is classified as hazardous and to define the scope of subsequent toxicological testing.

Modern acute oral toxicity testing is conducted in accordance with the principles of the 3Rs (Replacement, Reduction, and Refinement), which seek to minimize animal suffering and animal use. The traditional LD50 test (OECD Test Guideline 401) was formally deleted and replaced by refined alternative methods that classify substances into globally harmonized acute toxicity categories using far fewer animals. All studies intended for regulatory submission must be performed in GLP-compliant, accredited third-party laboratories following internationally recognized test guidelines.

Testing Samples

New Chemical Substances for Registration

The primary sample type consists of substances undergoing registration or notification as new chemicals, including research compounds not listed on existing chemical inventories, site-limited intermediates, imported substances below or above regulatory volume thresholds, and polymers with potentially leachable low-molecular-weight fractions. Both registration-grade and commercial-grade materials may be tested, provided their composition is fully characterized.

Industrial and Commercial Chemical Products

Testing is also performed on industrial raw materials, monomers, additives, catalysts, dyes, surfactants, agrochemical active ingredients and their intermediates, battery electrolytes and other specialty chemicals, electronic chemicals, and biocidal substances for which acute oral toxicity classification is required.

Sample Requirements

To ensure the validity of the study, the submitting party should provide the following:

• Test substance quantity: typically 20–100 g (or mL) depending on the selected test method and dose levels.
• Chemical identity documentation: CAS number, molecular formula, structural formula, and purity certificate.
• Physical-chemical properties: appearance, water solubility, stability, vapor pressure, and pH where applicable.
• Recommended vehicle and known solubility information, plus storage conditions and expiration date.
• Safety handling precautions to protect laboratory personnel during test article preparation and dosing.

Testing Items

A complete acute oral toxicity study generates the following core data items:

• LD50 value with confidence intervals, or a dose range within which the LD50 falls, depending on the classification-based method used.
• GHS acute toxicity category (Category 1 through Category 5) based on the oral LD50 cut-off values, supporting classification and labeling under the GB 30000 series standards and the UN GHS framework.
• Mortality record: number of deceased animals per dose group, time of death, and dose–response relationship.
• Clinical observations: onset, nature, severity, and duration of toxic signs such as piloerection, lethargy, tremors, convulsions, salivation, dyspnea, coma, and abnormal posture.
• Body weight evolution: individual weights recorded before dosing, weekly thereafter, and at termination.
• Gross necropsy findings: macroscopic examination of major organs and tissues of all animals that died or were sacrificed at study termination.
• Study conclusion: hazard classification, target organ indications, and recommendations for subsequent testing such as 28-day repeat-dose studies.

Testing Methods

Acute oral toxicity studies are conducted in GLP-certified facilities using healthy young adult rodents, with the rat as the preferred species, although mice may also be used with scientific justification. The test substance is administered by oral gavage after an appropriate fasting period (typically 4–6 hours for rats), and animals are observed for clinical signs for at least 14 days. The internationally accepted test guidelines are summarized below.

OECD Test Guideline 420: Fixed Dose Procedure

This method avoids using death as an endpoint. Animals are dosed sequentially at fixed dose levels (5, 50, 300, or 2000 mg/kg) and observed for signs of evident toxicity rather than lethality. The results allow assignment of a substance to one of the GHS hazard categories while using substantially fewer animals.

OECD Test Guideline 423: Acute Toxic Class Method

This stepwise procedure administers a single fixed dose to groups of three animals of one sex per step. Depending on the mortality observed, dosing proceeds at the next higher or lower fixed level. It is one of the most widely used methods for new chemical registration because it reliably classifies substances into GHS categories with minimal animal use.

OECD Test Guideline 425: Up-and-Down Procedure

This method doses animals one at a time in a sequential manner, adjusting the next dose up or down based on the outcome of the previous animal. It allows point estimation of the LD50 with confidence intervals and is particularly efficient for substances expected to be of low to moderate toxicity.

Chinese National Standard GB/T 21603

GB/T 21603 specifies the test method of acute oral toxicity for chemicals in China and is harmonized with the OECD alternative guidelines. It defines the requirements for test animals, dose administration, observation periods, and reporting, and is widely referenced in submissions to Chinese regulatory authorities alongside OECD protocols.

Additional Recognized Protocols

Depending on the destination market, studies may also follow the US EPA OCSPP Test Guideline 870.1100 (Acute Oral Toxicity) or other national standards equivalent to the OECD guidelines. In all cases, dose volume is typically limited to a maximum of 10 mL/kg body weight for aqueous solutions and lower volumes for oily vehicles, and vehicle control considerations are documented.

Applications

Acute oral toxicity test reports serve multiple regulatory and commercial purposes:

• New chemical substance registration in China under MEE Order No. 12, supporting both simplified and regular registration dossiers for substances not on the IECSC.
• REACH registration in the European Union, where acute oral toxicity is a standard information requirement at tonnage bands of one tonne per year and above.
• GHS classification and labeling, enabling assignment of hazard pictograms, signal words, and precautionary statements under the GB 30000 series, CLP Regulation, and other national implementations.
• Safety data sheet (SDS) compilation, where the acute toxicity value determines the classification entries in Section 2 and Section 11.
• Transport classification, informing the assignment of dangerous goods classes and packing groups for certain regulated shipments.
• Dose-range finding for subacute, subchronic, and reproductive toxicity studies, where the acute study guides the selection of dose levels.
• Occupational health risk assessment, exposure control measures, and emergency response planning for manufacturing and handling operations.

FAQ

What is the LD50 and why is it important?

The LD50 is the dose of a substance that causes mortality in 50% of a test population under defined experimental conditions. It is the key quantitative benchmark for comparing the relative acute toxicity of chemicals and directly determines the GHS acute toxicity hazard category.

Which test method should be selected?

The choice among OECD TG 420, 423, and 425 depends on the expected toxicity range, the required precision of the LD50 estimate, and the preferences of the receiving regulatory authority. When no preliminary information is available, the Acute Toxic Class Method (TG 423) is often selected because of its balance between reliability and animal welfare.

How long does the test take?

A standard study, including animal acclimation, dosing, the 14-day observation period, necropsy, and report preparation, is typically completed within four to six weeks after sample receipt.

Is GLP compliance mandatory?

Yes. Regulatory authorities in China, the EU, the United States, and most OECD member countries only accept toxicity data generated in laboratories operating under the OECD Principles of Good Laboratory Practice. Always confirm GLP status and accreditation before commissioning a study.

Can existing data or computational approaches replace testing?

In some registration scenarios, read-across from structurally analogous substances or validated QSAR predictions may be used to support data-waiving requests, subject to regulatory approval. However, for most new chemical substances without adequate analogs, experimental acute oral toxicity testing remains the required basis for hazard classification.